www.biotech.co.nz

INNOVATION IN THE

CITY

www.biotech.co.nz

Economic complexity: Germany vs NZ

• Connect• Collaborate• Diversify• Scale-up (Adapted from Shaun Hendy & Paul Callaghan 2014)

www.biotech.co.nz

Key indicators Switzerland Sweden Germany Denmark New Zealand

GDP/capita US$ 45,000 42,000 39,000 38,000 29,000

Total R&D expenditure

7 4 8 6 28

Hi-tech manufacturing

3 21 5 23 75

Cluster development

8 10 6 18 39

Academic-industry collaboration

1 7 11 20 22

Ease of starting a business

61 17 75 18 1

GDP/capita vs complexity, connectivity -global rankings (Global Innovation Index 2013)

www.biotech.co.nz

Progress made in the city

Connect: NZTE, ATEED, CI, NZIC, IIB, WQ

Commercialisation: CI, KiwiNet, Return on Science, Health Innovation Hub, Universities, CRIs, ICEHOUSE, VCs, IP firms

Clusters: F&B – Manukau, Foodbowl, UoA F/H programme, P&F Res ICT – WQ Innovation Precinct, city-wide Health technologies: Grafton, Newmarket (tech park?), Mt Wellington, Henderson Materials, manufacturing: Tamaki, Mt Wellington, city-wide

Ecosystem: industry networks, workshops, Bioscience Enterprise Forums

www.biotech.co.nz

Still to do in the city – change attitudes

Academia:• Industry engagement strategy • What are the market needs?• Change staff attitudes• Set expectations and incentives• Staff exchanges

Industry:• Increase R&D investment• Connect and collaborate• Maximise local strengths• Staff exchanges• External market focus

www.biotech.co.nz

Still to do in the city – scale up

Make it a priority to attract multinational companies:• R&D centres• High-tech manufacturing• Tailored value propositions• Strategy and targets• Regional collaboration• Job creation• Skill retention

www.biotech.co.nz

A GREAT BIG

THANK YOUFOR ALL YOUR SUPPORT FOR THE IIB AND

THE BIOSCIENCE ENTERPRISE PROGRAMME